Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|October 8, 2013
Strategies for improving outcomes in NSCLC: a look to the futureRolf Stahel, Solange Peters, Paul Baas, et al.Bioscience Reports|June 7, 2012
Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cellsHiu-Fung Yuen, Olga Abramczyk, Grant Montgomery, et al.Histopathology|May 16, 2013
Guidelines and considerations for conducting experiments using tissue microarraysMohammad Ilyas, Heike Grabsch, Ian O Ellis, et al.BMJ Open|November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centresDean Fennell, Daniel Griffiths, Zina Eminton, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2015
Perspectives of novel imaging techniques for staging, therapy response assessment, and monitoring of surveillance in lung cancer: summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging WorkshopThomas Henzler, Peter Goldstraw, Frederik Wenz, et al.ESMO Open|February 14, 2018
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapyChristian Manegold, Alex Adjei, Federico Bussolino, et al.The Lancet. Oncology|March 25, 2015
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trialLee M Krug, Hedy L Kindler, Hilary Calvert, et al.NPJ Precision Oncology|March 12, 2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancerGary Middleton, Helen L Robbins, Peter Fletcher, et al.British Journal of Cancer|September 30, 2021
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesotheliomaElisabet Aliagas, Ania Alay, Maria Martínez-Iniesta, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2016
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLCChristian Manegold, Anne-Marie C Dingemans, Jhanelle E Gray, et al.Pageof 3